Picture of Adherium logo

ADR — Adherium News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Adherium Says Astrazeneca Selected Co's Hailie Smartinhaler Platform For Clinical Trial

May 24 (Reuters) - Adherium Ltd  ADR.AX :
    * ASTRAZENECA HAS SELECTED CO'S HAILIE SMARTINHALER PLATFORM
FOR
CLINICAL TRIAL
    * CONTRACT IS VALUED AT A$1.1M OVER COURSE OF 3 YEARS

Further company coverage:  ADR.AX 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Adherium

See all news